Company Filing History:
Years Active: 2016
Title: Innovations of Cheol-Soo Lee in Radioactive Pharmaceuticals
Introduction
Cheol-Soo Lee is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of radioactive pharmaceuticals, particularly through his innovative patent that enhances the synthesis of F-18 labeled compounds. His work is vital for advancements in medical imaging and treatment.
Latest Patents
Cheol-Soo Lee holds a patent for an "Apparatus and method for synthesizing F-18 labeled radioactive pharmaceuticals." This invention describes a method and apparatus for synthesizing an F-18 labeled radioactive pharmaceutical by labeling a precursor with an F-18 radioactive isotope. The process involves reacting the labeled precursor to obtain a labeled pharmaceutical, separating impurities from the labeled pharmaceutical to provide a purified labeled pharmaceutical, and collecting the purified labeled pharmaceutical. The apparatus includes a labeling cartridge that contains the precursor, receives the isotope, and facilitates a labeling reaction. Additionally, a synthesizing container is utilized to hydrolyze the labeled precursor, and a separation cartridge is employed to separate impurities into polar and nonpolar compounds.
Career Highlights
Cheol-Soo Lee is affiliated with the Sogang University Research Foundation, where he continues to contribute to research and development in the field of pharmaceuticals. His innovative work has garnered attention and respect within the scientific community.
Collaborations
Cheol-Soo Lee collaborates with notable colleagues, including Dae-Yoon Chi and Eun-Young Heo. Their combined expertise enhances the research efforts at Sogang University Research Foundation.
Conclusion
Cheol-Soo Lee's contributions to the synthesis of radioactive pharmaceuticals represent a significant advancement in medical technology. His innovative patent and collaborative efforts continue to impact the field positively.